{"title":"Anorexia nervosa in later life.","authors":"W A Price, M R Babai, M S Torem","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Anorexia nervosa is generally considered a disease of adolescence. However, recently there has been a growing number of case reports of anorexia nervosa occurring in later life. Physicians must be aware of the fact that anorexia nervosa can occur well into the fifth, sixth, and seventh decades of life. Three cases of probable anorexia nervosa in later life are presented. When confronted with cases of unexplained weight loss, physicians should include anorexia nervosa in their differential diagnosis and pursue the answers to questions that will help make the diagnosis.</p>","PeriodicalId":77808,"journal":{"name":"The Hillside journal of clinical psychiatry","volume":"8 2","pages":"144-51"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14680144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Regional cerebral blood flow and neuropsychological functioning among adolescent psychiatric inpatients.","authors":"M M Quattrocchi, A M Walker, C J Golden, A J Fix","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Relationships between regional cerebral blood flow (rCBF) and the Luria-Nebraska Neuropsychological Battery (LNNB) were examined utilizing 15 adolescent psychiatric inpatients. Significant correlations were obtained between the gray matter measure on the rCBF and those scales on the LNNB more related to nonverbal function.</p>","PeriodicalId":77808,"journal":{"name":"The Hillside journal of clinical psychiatry","volume":"8 2","pages":"174-82"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14680147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Persistent tardive dyskinesia associated with amoxapine therapy--two case reports.","authors":"C C Huang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Two patients with depression were treated with amoxapine for 3 to 5 years and subsequently developed persistent tardive dyskinesia. The author stresses caution in regard to the long term use of amoxapine.</p>","PeriodicalId":77808,"journal":{"name":"The Hillside journal of clinical psychiatry","volume":"8 2","pages":"209-13"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14679199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Serum salivary isoamylase levels in patients with anorexia nervosa, bulimia or bulimia nervosa.","authors":"B J Blinder, J Hagman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Salivary isoamylase levels were studied in a sample of 35 women with bulimia, anorexia nervosa, or bulimia nervosa. Salivary isoamylase elevation was related to the presence of sham eating, evidenced by elevated isoamylase values in patients with bulimia nervosa or bulimia, and depressed isoamylase values in patients with anorexia nervosa. Salivary isoamylase levels may provide insight and have bearing on the functional interrelationship between appetite regulation and ingestive behavior in patients with eating disorders, as abnormalities may occur during both the cephalic as well as the oral phase of eating.</p>","PeriodicalId":77808,"journal":{"name":"The Hillside journal of clinical psychiatry","volume":"8 2","pages":"152-63"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14680145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G C Davis, D M Simpson, D Foster, Z Arison, M Post
{"title":"Reliability of Andreasen's thought, language and communications disorder scale.","authors":"G C Davis, D M Simpson, D Foster, Z Arison, M Post","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The study of disordered thinking has been hampered by a lack of clinical instruments aimed at the measurement of thought disorder. Andreasen has proposed a rating scale for thought disorder (TLC) and reported on its reliability and preliminary aspects of its validity. In our study, a psychiatrist and physician assistant rated 98 psychiatric inpatients using the TLC and BPRS. Interrater reliability ranged from 0.35 to 0.80 (weighted kappa) on 18 aspects of thought disorder and one global item. The order of reliability for the 18 individual items was strongly correlated between the Andreasen sample and our own (r = 0.77). While the BPRS thought disorder scale was significantly related to the global rating of thought disorder on the TLC (r = 0.71), only half of the variance in thought disorder measured by the TLC was accounted for by the BPRS factor. Thus, this study supports Andreasen's contention that the TLC is a reliable instrument and suggests that the instrument may provide additional information about thinking disorders.</p>","PeriodicalId":77808,"journal":{"name":"The Hillside journal of clinical psychiatry","volume":"8 1","pages":"25-33"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14863837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Dantrolene sodium as a possible prophylactic agent against N.M.S.","authors":"M S Lesser, M Kahan, R Brenner, D Nayak","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77808,"journal":{"name":"The Hillside journal of clinical psychiatry","volume":"8 1","pages":"34-7"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14863839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Long-term amitriptyline in chronic depression.","authors":"E Giller, D Bialos, L Harkness, P Jatlow, M Waldo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Medication was discontinued under a placebo-controlled, double-blind, six-month protocol with 17 chronically depressed patients who had been taking an average daily dose of 138 mg amitriptyline (AMI) for an average of 3.7 years. Only one of nine patients became depressed on active medication, while of the 15 patients receiving a placebo trial, 11 had a depressive recurrence at an average time of 9.3 weeks. These 11 were subsequently restarted on AMI, and responded similarly to the way in which acutely depressed patients respond, although the patients showed either a need for less AMI or decreased symptoms, compared to entry. Tolerance did not develop to anticholinergic side-effects during long-term medication. Twelve of the 15 patients on placebo showed a withdrawal reaction during the first few weeks of tapered AMI discontinuation which could be distinguished from recurrence of depression. This study suggests that the majority of patients on long-term antidepressant will suffer a recurrence of depressive symptoms when the medication is discontinued.</p>","PeriodicalId":77808,"journal":{"name":"The Hillside journal of clinical psychiatry","volume":"7 1","pages":"16-33"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15011252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Psychiatric diagnosis and psychological symptoms in impotence.","authors":"L R Derogatis, J K Meyer, S Kourlesis","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A sample of 137 males who presented with a principal complaint of impotence were assessed regarding manifest psychopathology through DSM-III psychiatric diagnosis and the SCL-90-R, a self-report symptom inventory. Contrasts in self-reported symptoms among dysfunctional groups assigned different DSM-III diagnoses proved to be very significant, as were contrasts with patients free of current psychiatric diagnoses. When the sample was separated into the three groups of organic etiology, psychogenic etiology with psychiatric diagnosis, and psychogenic etiology without psychiatric diagnosis, few significant differences in group profiles were uncovered. Findings of the study lend strong support to the notion that males with erectile sexual dysfunction reveal disproportionate levels of psychological symptoms and psychopathology. The results failed to confirm the premise that biogenic versus psychogenic etiologies in impotence can be effectively identified solely on the basis of the psychological symptom picture.</p>","PeriodicalId":77808,"journal":{"name":"The Hillside journal of clinical psychiatry","volume":"7 2","pages":"120-33"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15187688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Paradoxes of suicide risk assessment.","authors":"J A Motto","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77808,"journal":{"name":"The Hillside journal of clinical psychiatry","volume":"7 2","pages":"109-19"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15188626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The use of propranolol in the treatment of anxiety disorders.","authors":"R J Fonte, J M Stevenson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The authors review the available literature on the use of propranolol in the treatment of anxiety disorders. First studied in 1966, propranolol has been shown to be most effective in the control of certain somatic symptoms associated with anxiety. Despite these studies, however, it is still not certain where this beta-adrenergic blocker fits into the overall treatment of anxiety disorders. Reasons for this uncertainty and other related problems are discussed.</p>","PeriodicalId":77808,"journal":{"name":"The Hillside journal of clinical psychiatry","volume":"7 1","pages":"54-62"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15011253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}